Kenvue stock enters a leadership transition before deal close

Published on 10/04/2026 at 11:20 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Kenvue stock was last at USD 17.20 on October 2, 2026, within a USD 14.02 to USD 20.13 52-week range. Q2 revenue rose 3.0% to USD 3.955 billion.

Isometrische 3D-Illustration einer Konsumgüter-Lieferkette mit Fabrik und Lager — Isometrisches 3D-Diagramm der Wertschöpfungskette illustriert Produktion und Vertrieb von Kenvue ISIN US49177J1025, Illustration mit AI erstellt.

Kenvue (ISIN US49177J1025) enters a leadership transition before its planned combination with Kimberly-Clark, while the stock was last at USD 17.20 on the NYSE on October 2, 2026 at 4:00 p.m. ET. The reference price was down 0.12% from the prior close, giving investors a market value of USD 33.0 billion.

Deal leadership takes shape

According to Kimberly-Clark on October 1, 2026, Carlos De Jesus, currently Kenvue's Group President for North America, is set to lead North America after the acquisition closes. Leonardo Curado, Kenvue's current Latin America leader, is scheduled to take charge of Europe, the Middle East and Africa on January 1, 2027.

The transaction remains expected to close in Q4 2026, subject to regulatory approvals and customary closing conditions, according to Kimberly-Clark. The leadership map makes integration execution a central valuation issue because Kenvue is moving toward a combined consumer health and personal care platform.

Q2 sales rose 3.0 percent

Kenvue reported that Q2 2026 net sales increased 3.0% to USD 3.955 billion, while diluted EPS increased 9% to USD 0.24. Adjusted diluted EPS rose 7% to USD 0.31, giving the latest report a clear comparison with the prior-year period.

The operating picture was mixed by segment. Kenvue said its Q2 organic sales increased 1.6%, while the company highlighted its third consecutive quarter of net and organic sales growth. That combination supports the deal case, but the stock remains sensitive to how successfully the new leadership structure converts brand scale into sustained earnings growth.

Analysts see 12.0 percent upside

MarketBeat reported on September 11, 2026 that 15 research firms carried a Hold consensus, with 12 Hold ratings and three Buy ratings. The average 12-month price target was USD 19.27, which places the target 12.0% above the October 2 reference price of USD 17.20.

Stock stays below yearly high

Kenvue was last at USD 17.20 on the NYSE on October 2, 2026 at 4:00 p.m. ET, with a session range of USD 17.16 to USD 17.38 and volume of 13,915,844 shares. Its 52-week range was USD 14.02 to USD 20.13, leaving the stock 14.6% below its yearly high.